AL amyloidosis
J&J’s Darzalex Faspro is first US therapy for rare blood disorder
Phil Taylor
AL amyloidosis, Alexion, Janssen, Johnson & Johnson, rare disease, Takeda
0 Comment
X
J&J’s Darzalex Faspro is first US therapy for rare blood disorder
https://pharmaphorum.com/news/jjs-darzalex-faspro-is-first-us-therapy-for-rare-blood-disorder/
Chasing Janssen, Alexion and Caelum start phase 3 AL amyloidosis trial
Richard Staines
AL amyloidosis, Alexion, Caelum Biosciences, Rare diseases
0 Comment
X
Chasing Janssen, Alexion and Caelum start phase 3 AL amyloidosis trial
https://pharmaphorum.com/news/chasing-janssen-alexion-and-caelum-start-phase-3-al-amyloidosis-trial/
Janssen files Darzalex Faspro for rare disease light chain amyloidosis
Richard Staines
AL amyloidosis, Janssen, Johnson & Johnson, Rare diseases, Takeda
0 Comment
X
Janssen files Darzalex Faspro for rare disease light chain amyloidosis
https://pharmaphorum.com/news/janssen-files-new-darzalex-for-rare-disease-light-chain-amyloidosis/